Northview Announces Second Equity Investment into Amp Human

March 8, 2021 – Northview LifeSciences will be partaking in a second equity investment into portfolio company Amp Human. Amp Human has developed an innovative performance enhancing system to improve results in athletics and sport. Specific use of this second investment will be to fund the launch of their new topical vitamin D product, D+ Lotion.

Amp Human Website

Northview LifeSciences Advancing the Business of Science